Bordetella cell surface modification and pathogenesis

博德特氏菌细胞表面修饰和发病机制

基本信息

  • 批准号:
    10117511
  • 负责人:
  • 金额:
    $ 25.33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-12-04 至 2022-11-30
  • 项目状态:
    已结题

项目摘要

The Gram-negative bacterium Bordetella pertussis is a human-restricted pathogen that causes severe respiratory infections and the disease whooping cough or pertussis. Despite high levels and widespread vaccination, there has been a world-wide rise in B. pertussis infections and pertussis. This resurgence is attributed to the ineffectiveness of the current acellular pertussis vaccines to control bacterial numbers in the nasopharynx, bacterial transmission and generation of shorter-lived immunity. How B. pertussis survives effectively in the respiratory tract and circulates in the community is poorly understood. In order to control the resurgence of pertussis, it is critical to discover new strategies and identify new pathogenesis-associated loci and factors. The draABCD locus identified in our laboratory promotes in vitro (i) the resistance to killing by anti-microbial peptides and proteins (AMPs); (ii) polymorphonuclear leukocytes and (iii) the formation of biofilms. We hypothesize that dra is critical for survival of B. pertussis in the mouse respiratory tract. In Specific aim 1, we will utilize well-established mouse models of intranasal infection to examine its role in colonization and biofilm formation in the respiratory tract organs. We will also test whether dra promotes adherence to respiratory epithelium by using epithelial cells lines and respiratory explants. The Dra proteins catalyze the addition of D-alanine in an outer membrane-associated protease-susceptible component. This mechanism of surface modification is distinct from the polysaccharide modification carried out by other known bacterial loci. The Dra-modified surface factor (DMF) is unknown. In Specific Aim 2, using fractionation techniques and mass spectrometry, we will identify the DMF. This work will uncover new virulence strategies that will inform on the reasons of the resurgence of pertussis. Studies of the dra locus and discovering the identity of the DMF will provide important biochemical and biological insights resulting in advanced understanding of surface alterations in B. pertussis. Outcomes from this research will result in targeting of the dra locus and DMF for developing better vaccines and alternative therapeutics.
革兰氏阴性细菌百日咳博德特菌是一种人类限制性病原体,可引起严重的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RAJENDAR K DEORA其他文献

RAJENDAR K DEORA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RAJENDAR K DEORA', 18)}}的其他基金

Interdisciplinary Program in Microbe-Host Biology
微生物-宿主生物学跨学科项目
  • 批准号:
    10333941
  • 财政年份:
    2022
  • 资助金额:
    $ 25.33万
  • 项目类别:
Interdisciplinary Program in Microbe-Host Biology
微生物-宿主生物学跨学科项目
  • 批准号:
    10681206
  • 财政年份:
    2022
  • 资助金额:
    $ 25.33万
  • 项目类别:
Identification of novel immunogenic proteins from Bordetella pertussis
百日咳博德特氏菌新型免疫原性蛋白的鉴定
  • 批准号:
    10306163
  • 财政年份:
    2021
  • 资助金额:
    $ 25.33万
  • 项目类别:
Identification of novel immunogenic proteins from Bordetella pertussis
百日咳博德特氏菌新型免疫原性蛋白的鉴定
  • 批准号:
    10627863
  • 财政年份:
    2021
  • 资助金额:
    $ 25.33万
  • 项目类别:
Identification of novel immunogenic proteins from Bordetella pertussis
百日咳博德特氏菌新型免疫原性蛋白的鉴定
  • 批准号:
    10425440
  • 财政年份:
    2021
  • 资助金额:
    $ 25.33万
  • 项目类别:
Bordetella cell surface modification and pathogenesis
博德特氏菌细胞表面修饰和发病机制
  • 批准号:
    10312117
  • 财政年份:
    2020
  • 资助金额:
    $ 25.33万
  • 项目类别:
Enhancing efficacy of pertussis vaccines
增强百日咳疫苗的功效
  • 批准号:
    9158545
  • 财政年份:
    2016
  • 资助金额:
    $ 25.33万
  • 项目类别:
Enhancing efficacy of pertussis vaccines
增强百日咳疫苗的功效
  • 批准号:
    9573826
  • 财政年份:
    2016
  • 资助金额:
    $ 25.33万
  • 项目类别:
Regulation of biofilm formation and pathogenesis in Bordetella pertussis
百日咳博德特氏菌生物膜形成和发病机制的调控
  • 批准号:
    9092038
  • 财政年份:
    2016
  • 资助金额:
    $ 25.33万
  • 项目类别:
FASEB SRC ON MICROBIAL GLYCOBIOLOGY
FASEB SRC 微生物糖生物学
  • 批准号:
    8718520
  • 财政年份:
    2014
  • 资助金额:
    $ 25.33万
  • 项目类别:

相似海外基金

Active immunization mouse model by cN1A peptides
cN1A肽主动免疫小鼠模型
  • 批准号:
    18K15370
  • 财政年份:
    2018
  • 资助金额:
    $ 25.33万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of an efficient oocyte collection method using active immunization against inhibin in cynomolgus monkeys.
使用食蟹猴主动免疫抑制素开发有效的卵母细胞收集方法。
  • 批准号:
    17H06766
  • 财政年份:
    2017
  • 资助金额:
    $ 25.33万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Passive and Active Immunization for Pneumocystis
肺孢子虫的被动和主动免疫
  • 批准号:
    9182862
  • 财政年份:
    2015
  • 资助金额:
    $ 25.33万
  • 项目类别:
Active Immunization for Treating Methamphetamine Abuse
治疗甲基苯丙胺滥用的主动免疫
  • 批准号:
    8136035
  • 财政年份:
    2007
  • 资助金额:
    $ 25.33万
  • 项目类别:
Active Immunization for Treating Methamphetamine Abuse
治疗甲基苯丙胺滥用的主动免疫
  • 批准号:
    7921670
  • 财政年份:
    2007
  • 资助金额:
    $ 25.33万
  • 项目类别:
Can passive or active immunization alter the course of infection with circoviral DNA?
被动或主动免疫可以改变圆环病毒 DNA 的感染过程吗?
  • 批准号:
    306844-2004
  • 财政年份:
    2007
  • 资助金额:
    $ 25.33万
  • 项目类别:
    Special Research Opportunity Program - Project
Active Immunization for Treating Methamphetamine Abuse
治疗甲基苯丙胺滥用的主动免疫
  • 批准号:
    7502083
  • 财政年份:
    2007
  • 资助金额:
    $ 25.33万
  • 项目类别:
Active Immunization for Treating Methamphetamine Abuse
治疗甲基苯丙胺滥用的主动免疫
  • 批准号:
    7341002
  • 财政年份:
    2007
  • 资助金额:
    $ 25.33万
  • 项目类别:
Active Immunization for Treating Methamphetamine Abuse
治疗甲基苯丙胺滥用的主动免疫
  • 批准号:
    7679096
  • 财政年份:
    2007
  • 资助金额:
    $ 25.33万
  • 项目类别:
Passive-Active Immunization Strategies Against Pediatric AIDS
针对儿童艾滋病的被动-主动免疫策略
  • 批准号:
    7065729
  • 财政年份:
    2006
  • 资助金额:
    $ 25.33万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了